Fundraising Fox
Spyryx Biosciences
Research Triangle Park, US · Founded 2013 · Delaware corporation · 3 known investors
Find your way into Spyryx Biosciences
Sign up to see every warm intro you have to Spyryx Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spyryx Biosciences team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AJ
Andrew JordanExecutive
JT
John TaylorNamed on SEC filing
RT
Robert TarranNamed on SEC filing
Board
DR
Donald RoseBoard director
Investors · 3
5AM VenturesreportedSan Francisco · $100K – $4M
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · Not right? Tell us
Canaan PartnersreportedStamford · $500K – $20Mvia Tim Shannon · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M
How we know: a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$29.1M disclosed across 4 rounds · 2015–2018
▶$5.9MraisedOct 2018 · 7 investors · BiotechnologyRule 506(b)
▶$5.9MraisedOct 2018 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tim ShannonDirector
- Brian DanielsDirector
- Roger JeffsDirector
- Timm CrowderExecutive Officer, Promoter
- Christy ShafferDirector
- Robert TarranDirector
- Offering amount
- $6M
- Amount sold
- $5.9M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$5MraisedJul 2017 · 13 investors · BiotechnologyRule 506(b)
▶$5MraisedJul 2017 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew JordanDirector
- Tim ShannonDirector
- Christy ShafferDirector
- Robert TarranDirector
- Brian DanielsDirector
- John TaylorExecutive Officer, Director, Promoter
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$18.2MraisedMay 2015 · 13 investors · BiotechnologyRule 506(b)
▶$18.2MraisedMay 2015 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christy ShafferDirector
- John TaylorExecutive Officer, Director, Promoter
- Brian DanielsDirector
- Andrew JordanDirector
- Tim ShannonDirector
- Robert TarranDirector
- Offering amount
- $18.2M
- Amount sold
- $18.2M
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$15KraisedFeb 2015 · 1 investors · BiotechnologyRule 506(b)
▶$15KraisedFeb 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Donald RoseDirector
- Andrew JordanExecutive Officer, Director
- John TaylorExecutive Officer, Director, Promoter
- Robert TarranDirector
- Offering amount
- $1M
- Amount sold
- $15K
- Proceeds to insiders
- $10K
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Spyryx Biosciences's investors?
- Spyryx Biosciences's investors include 5AM Ventures, Canaan Partners, Hatteras Venture Partners.
- How much funding has Spyryx Biosciences raised?
- Spyryx Biosciences has disclosed $29.1M raised across 4 rounds.
- Where is Spyryx Biosciences headquartered?
- Spyryx Biosciences is headquartered in Research Triangle Park, US.